• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于转录组学的羟基红花黄色素A对急性肝损伤的作用机制

Mechanism of hydroxysafflor yellow A on acute liver injury based on transcriptomics.

作者信息

Hou Xiangmei, Zhang Ziying, Ma Yuehong, Jin Rong, Yi Bing, Yang Dongdong, Ma Lijie

机构信息

Inner Mongolia Key Laboratory of Molecular Biology, Inner Mongolia Medical University, Hohhot, China.

出版信息

Front Pharmacol. 2022 Sep 2;13:966759. doi: 10.3389/fphar.2022.966759. eCollection 2022.

DOI:10.3389/fphar.2022.966759
PMID:36120318
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9478418/
Abstract

To investigate how Hydroxysafflor yellow A (HSYA) effects acute liver injury (ALI) and what transcriptional regulatory mechanisms it may employ. Rats were randomly divided into five groups ( = 10): Control, Model, HSYA-L, HSYA-M, and HSYA-H. In the control and model groups, rats were intraperitoneally injected with equivalent normal saline, while in the HSYA groups, they were also injected with different amounts of HSYA (10, 20, and 40 mg/kg/day) once daily for eight consecutive days. One hour following the last injection, the control group was injected into the abdominal cavity with 0.1 ml/100 g of peanut oil, and the other four groups got the same amount of a peanut oil solution containing 50% CCl. Liver indexes were detected in rats after dissection, and hematoxylin and eosin (HE) dyeing was utilized to determine HSYA's impact on the liver of model rats. In addition, with RNA-Sequencing (RNA-Seq) technology and quantitative real-time PCR (qRT-PCR), differentially expressed genes (DEGs) were discovered and validated. Furthermore, we detected the contents of anti-superoxide anion (anti-O ) and hydrogen peroxide (HO), and verified three inflammatory genes (Icam1, Bcl2a1, and Ptgs2) in the NF-kB pathway by qRT-PCR. Relative to the control and HSYA groups, in the model group, we found 1111 DEGs that were up-/down-regulated, six of these genes were verified by qRT-PCR, including Tymp, Fabp7, Serpina3c, Gpnmb, Il1r1, and Creld2, indicated that these genes were obviously involved in the regulation of HSYA in ALI model. Membrane rafts, membrane microdomains, inflammatory response, regulation of cytokine production, monooxygenase activity, and iron ion binding were significantly enriched in GO analysis. KEGG analysis revealed that DEGs were primarily enriched for PPAR, retinol metabolism, NF-kB signaling pathways, etc. Last but not least, compared with the control group, the anti-O content was substantially decreased, the HO content and inflammatory genes (Icam1, Bcl2a1, and Ptgs2) levels were considerably elevated in the model group. Compared with the model group, the anti-O content was substantially increased, the HO content and inflammatory genes (Icam1, Bcl2a1, and Ptgs2) levels were substantially decreased in the HSYA group ( < 0.05). HSYA could improve liver function, inhibit oxidative stress and inflammation, and improve the degree of liver tissue damage. The RNA-Seq results further verified that HSYA has the typical characteristics of numerous targets and multiple pathway. Protecting the liver from damage by regulating the expression of Tymp, Fabp7, Serpina3c, Gpnmb, Il1r1, Creld2, and the PPAR, retinol metabolism, NF-kappa B signaling pathways.

摘要

为研究羟基红花黄色素A(HSYA)对急性肝损伤(ALI)的影响及其可能采用的转录调控机制。将大鼠随机分为五组(每组n = 10):对照组、模型组、HSYA-L组、HSYA-M组和HSYA-H组。对照组和模型组大鼠腹腔注射等量生理盐水,而HSYA组大鼠连续八天每天腹腔注射不同剂量的HSYA(10、20和40 mg/kg/天)。末次注射后1小时,对照组腹腔注射0.1 ml/100 g花生油,其他四组注射等量含50% CCl₄的花生油溶液。解剖大鼠后检测肝脏指标,采用苏木精-伊红(HE)染色法观察HSYA对模型大鼠肝脏的影响。此外,利用RNA测序(RNA-Seq)技术和定量实时聚合酶链反应(qRT-PCR)发现并验证差异表达基因(DEGs)。进一步检测抗超氧阴离子(抗-O₂⁻)和过氧化氢(H₂O₂)含量,并通过qRT-PCR验证核因子κB(NF-κB)通路中的三个炎症基因(Icam1、Bcl2a1和Ptgs2)水平。与对照组和HSYA组相比,模型组发现1111个上调/下调的DEGs,其中6个基因经qRT-PCR验证,包括Tymp、Fabp7、Serpina3c、Gpnmb、Il1r1和Creld2,表明这些基因明显参与HSYA对ALI模型的调控。基因本体(GO)分析显示,膜筏、膜微区、炎症反应、细胞因子产生的调控、单加氧酶活性和铁离子结合等功能显著富集。京都基因与基因组百科全书(KEGG)分析表明,DEGs主要富集于过氧化物酶体增殖物激活受体(PPAR)、视黄醇代谢、NF-κB信号通路等。最后,与对照组相比,模型组抗-O₂⁻含量显著降低,H₂O₂含量和炎症基因(Icam1、Bcl2a1和Ptgs2)水平显著升高。与模型组相比,HSYA组抗-O₂⁻含量显著增加,H₂O₂含量和炎症基因(Icaml、Bcl2a1和Ptgs2)水平显著降低(P < 0.05)。HSYA可改善肝功能,抑制氧化应激和炎症反应,减轻肝组织损伤程度。RNA-Seq结果进一步证实HSYA具有多靶点、多通路的典型特征,通过调节Tymp、Fabp7、Serpina3c、Gpnmb、Il1r1、Creld2的表达以及PPAR、视黄醇代谢、NF-κB信号通路发挥肝脏保护作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7726/9478418/e5142df801c5/fphar-13-966759-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7726/9478418/106a89be4757/fphar-13-966759-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7726/9478418/17aaa375c51b/fphar-13-966759-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7726/9478418/184688920d03/fphar-13-966759-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7726/9478418/f179d24d425f/fphar-13-966759-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7726/9478418/c7371b1d16ed/fphar-13-966759-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7726/9478418/c4a563efc17c/fphar-13-966759-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7726/9478418/38e5bbc1bdb8/fphar-13-966759-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7726/9478418/1caab62a38a8/fphar-13-966759-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7726/9478418/e5142df801c5/fphar-13-966759-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7726/9478418/106a89be4757/fphar-13-966759-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7726/9478418/17aaa375c51b/fphar-13-966759-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7726/9478418/184688920d03/fphar-13-966759-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7726/9478418/f179d24d425f/fphar-13-966759-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7726/9478418/c7371b1d16ed/fphar-13-966759-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7726/9478418/c4a563efc17c/fphar-13-966759-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7726/9478418/38e5bbc1bdb8/fphar-13-966759-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7726/9478418/1caab62a38a8/fphar-13-966759-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7726/9478418/e5142df801c5/fphar-13-966759-g009.jpg

相似文献

1
Mechanism of hydroxysafflor yellow A on acute liver injury based on transcriptomics.基于转录组学的羟基红花黄色素A对急性肝损伤的作用机制
Front Pharmacol. 2022 Sep 2;13:966759. doi: 10.3389/fphar.2022.966759. eCollection 2022.
2
Integrating Network Pharmacology and Transcriptomic Strategies to Explore the Pharmacological Mechanism of Hydroxysafflor Yellow A in Delaying Liver Aging.基于网络药理学和转录组学策略探讨羟基红花黄色素 A 延缓肝老化的药理机制
Int J Mol Sci. 2022 Nov 18;23(22):14281. doi: 10.3390/ijms232214281.
3
Protective Effect of Hydroxysafflor Yellow A on Inflammatory Injury in Chronic Obstructive Pulmonary Disease Rats.羟基红花黄色素 A 对慢性阻塞性肺疾病大鼠炎症损伤的保护作用。
Chin J Integr Med. 2019 Oct;25(10):750-756. doi: 10.1007/s11655-018-2577-2. Epub 2018 Dec 27.
4
Protective effect of hydroxysafflor yellow A on bleomycin- induced pulmonary inflammation and fibrosis in rats.羟基红花黄色素A对博莱霉素诱导的大鼠肺部炎症和纤维化的保护作用。
Chin J Integr Med. 2018 Jan;24(1):32-39. doi: 10.1007/s11655-017-2094-z. Epub 2018 Jan 3.
5
HSYA alleviates secondary neuronal death through attenuating oxidative stress, inflammatory response, and neural apoptosis in SD rat spinal cord compression injury.羟基红花黄色素A通过减轻SD大鼠脊髓压迫损伤中的氧化应激、炎症反应和神经细胞凋亡来减轻继发性神经元死亡。
J Neuroinflammation. 2017 May 3;14(1):97. doi: 10.1186/s12974-017-0870-1.
6
Protective effect of hydroxysafflor yellow A alone or in combination with acetylglutamine on cerebral ischemia reperfusion injury in rat: A PET study using F-fuorodeoxyglucose.羟基红花黄色素 A 单独或联合乙酰谷氨酰胺对大鼠脑缺血再灌注损伤的保护作用:使用 F-氟脱氧葡萄糖的 PET 研究。
Eur J Pharmacol. 2018 Apr 15;825:119-132. doi: 10.1016/j.ejphar.2018.02.011. Epub 2018 Feb 10.
7
The Effect of Hydroxysafflor Yellow A on Inflammatory Injury in LPS-induced Endothelial Cell Injury Model through TLR4/NF-κB Pathway Based on Network Pharmacology and Experimental Verification.基于网络药理学和实验验证探讨羟基红花黄色素A通过TLR4/NF-κB通路对脂多糖诱导的内皮细胞损伤模型炎症损伤的影响
Curr Pharm Biotechnol. 2025;26(6):813-826. doi: 10.2174/0113892010311334240816101114.
8
Hydroxysafflor yellow A attenuates ischemia/reperfusion-induced liver injury by suppressing macrophage activation.羟基红花黄色素A通过抑制巨噬细胞活化减轻缺血/再灌注诱导的肝损伤。
Int J Clin Exp Pathol. 2014 Apr 15;7(5):2595-608. eCollection 2014.
9
Hydroxysafflor yellow A suppresses liver fibrosis induced by carbon tetrachloride with high-fat diet by regulating PPAR-γ/p38 MAPK signaling.羟基红花黄色素A通过调节PPAR-γ/p38 MAPK信号通路抑制高脂饮食联合四氯化碳诱导的肝纤维化。
Pharm Biol. 2014 Sep;52(9):1085-93. doi: 10.3109/13880209.2013.877491. Epub 2014 Mar 12.
10
Hydroxysafflor yellow A alleviates cerebral ischemia reperfusion injury by suppressing apoptosis via mitochondrial permeability transition pore.羟基红花黄色素A通过线粒体通透性转换孔抑制细胞凋亡减轻脑缺血再灌注损伤。
Phytomedicine. 2021 May;85:153532. doi: 10.1016/j.phymed.2021.153532. Epub 2021 Feb 28.

引用本文的文献

1
HPF Modulates the Differentiation of BMSCs into HLCs and Promotes the Recovery of Acute Liver Injury in Mice.高渗盐水通过调节骨髓间充质干细胞向肝样细胞分化促进急性肝损伤小鼠的恢复。
Int J Mol Sci. 2023 Mar 16;24(6):5686. doi: 10.3390/ijms24065686.
2
Integrating Network Pharmacology and Transcriptomic Strategies to Explore the Pharmacological Mechanism of Hydroxysafflor Yellow A in Delaying Liver Aging.基于网络药理学和转录组学策略探讨羟基红花黄色素 A 延缓肝老化的药理机制
Int J Mol Sci. 2022 Nov 18;23(22):14281. doi: 10.3390/ijms232214281.

本文引用的文献

1
Methyl 6-O-cinnamoyl-α-d-glucopyranoside Ameliorates Acute Liver Injury by Inhibiting Oxidative Stress Through the Activation of Nrf2 Signaling Pathway.6-O-肉桂酰-α-D-吡喃葡萄糖苷甲酯通过激活Nrf2信号通路抑制氧化应激来改善急性肝损伤。
Front Pharmacol. 2022 Apr 26;13:873938. doi: 10.3389/fphar.2022.873938. eCollection 2022.
2
SERP1 reduces inchoate acute hepatic injury through regulation of endoplasmic reticulum stress via the GSK3β/β‑catenin/TCF/LEF signaling pathway.SERP1 通过调节内质网应激通过 GSK3β/β-连环蛋白/TCF/LEF 信号通路减少早期急性肝损伤。
Mol Med Rep. 2022 Jun;25(6). doi: 10.3892/mmr.2022.12709. Epub 2022 Apr 8.
3
Identifying Potential New Gene Expression-Based Biomarkers in the Peripheral Blood Mononuclear Cells of Hepatitis B-Related Hepatocellular Carcinoma.
鉴定乙型肝炎相关肝细胞癌患者外周血单个核细胞中潜在的新型基因表达生物标志物。
Can J Gastroenterol Hepatol. 2022 Feb 28;2022:9541600. doi: 10.1155/2022/9541600. eCollection 2022.
4
Transient response of serpinA3 during cellular stress.细胞应激过程中丝氨酸蛋白酶抑制剂 A3 的瞬时反应。
FASEB J. 2022 Mar;36(3):e22190. doi: 10.1096/fj.202101912R.
5
Proteomic analysis of alcohol-associated hepatitis reveals glycoprotein NMB (GPNMB) as a novel hepatic and serum biomarker.酒精性肝炎的蛋白质组学分析揭示糖蛋白 NMB(GPNMB)作为一种新的肝和血清生物标志物。
Alcohol. 2022 Mar;99:35-48. doi: 10.1016/j.alcohol.2021.11.005. Epub 2021 Dec 17.
6
Hepatoprotective Potential of Pomegranate in Curbing the Incidence of Acute Liver Injury by Alleviating Oxidative Stress and Inflammatory Response.石榴通过减轻氧化应激和炎症反应抑制急性肝损伤发生率的肝脏保护潜力
Front Pharmacol. 2021 Nov 26;12:694607. doi: 10.3389/fphar.2021.694607. eCollection 2021.
7
Anti-inflammatory role of Gpnmb in adipose tissue of mice.Gpnmb 在小鼠脂肪组织中的抗炎作用。
Sci Rep. 2021 Oct 4;11(1):19614. doi: 10.1038/s41598-021-99090-6.
8
Multi-Omics Integration to Reveal the Mechanism of Hepatotoxicity Induced by Dictamnine.多组学整合揭示白鲜碱诱导肝毒性的机制
Front Cell Dev Biol. 2021 Sep 14;9:700120. doi: 10.3389/fcell.2021.700120. eCollection 2021.
9
Creld2 function during unfolded protein response is essential for liver metabolism homeostasis.Creld2 在未折叠蛋白反应中的功能对于肝脏代谢稳态至关重要。
FASEB J. 2021 Oct;35(10):e21939. doi: 10.1096/fj.202002713RR.
10
Caveolin-1 Deficiency Protects Mice Against Carbon Tetrachloride-Induced Acute Liver Injury Through Regulating Polarization of Hepatic Macrophages.窖蛋白-1 缺乏通过调节肝巨噬细胞极化保护小鼠免受四氯化碳诱导的急性肝损伤。
Front Immunol. 2021 Aug 9;12:713808. doi: 10.3389/fimmu.2021.713808. eCollection 2021.